drugset / Trial / NCT06362460
Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China
NaSingle-groupOpen-labelBasic science
Summary
This study is a single-center, open-label, and single-dose clinical study to evaluate the mass balance, biotransformation and pharmacokinetics of \[14C\]RAY1216 in healthy Chinese male participants, revealing the overall pharmacokinetic characteristics of RAY1216.
Timeline
- Start
- 2023-09-18
- Primary completion
- 2023-11-01
- Completion
- 2023-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RAY1216 | Small molecule | 400 mg | Oral |
Indications
No indication recorded.